Leishmania major: leishmanicidal activity of activated macrophages by interferon gamma or tumour necrosis factor. 1996

N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
Department of Parasitology, Faculty of Medicine, Alexandria University, Egypt.

Infective, stationary growth phase metacyclic promastigotes of Leishmania major were introduced to murine peritoneal macrophages and incubated with recombinant murine tumour necrosis factor (TNF) or with interferon gamma (IFN-gamma) in the presence of LPS. The leishmanicidal activity of macrophages was estimated by the visual counting of intracellular parasites as well as by the (3H) thymidine incorporation of the residual parasites. The culture supernatants were also collected for the estimation of nitrite (NO-2) and hydrogen peroxide (H2O2). The results showed that both (TNF) and (IFN-gamma) had a significant leishmanicidal effect, yet it was more pronounced with IFN-gamma. The production of NO-2 and H2O2 were also correlated with the increased leishmanicidal activity in the activated macrophages.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D008262 Macrophage Activation The process of altering the morphology and functional activity of macrophages so that they become avidly phagocytic. It is initiated by lymphokines, such as the macrophage activation factor (MAF) and the macrophage migration-inhibitory factor (MMIF), immune complexes, C3b, and various peptides, polysaccharides, and immunologic adjuvants. Activation, Macrophage,Activations, Macrophage,Macrophage Activations
D008297 Male Males
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D017737 Macrophages, Peritoneal Mononuclear phagocytes derived from bone marrow precursors but resident in the peritoneum. Peritoneal Macrophages,Macrophage, Peritoneal,Peritoneal Macrophage
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D018320 Leishmania major A parasitic hemoflagellate of the subgenus Leishmania leishmania that infects man and animals and causes cutaneous leishmaniasis (LEISHMANIASIS, CUTANEOUS) of the Old World. Transmission is by Phlebotomus sandflies. Leishmania (Leishmania) major,Leishmania tropica major,Leishmania leishmania major,Leishmania leishmania majors,Leishmania majors,Leishmania tropica majors,leishmania major, Leishmania,major, Leishmania leishmania,majors, Leishmania,majors, Leishmania leishmania,majors, Leishmania tropica,tropica major, Leishmania,tropica majors, Leishmania

Related Publications

N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
April 1996, Immunology,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
September 2014, The Journal of investigative dermatology,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
September 1996, Zentralblatt fur Bakteriologie : international journal of medical microbiology,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
January 1984, Clinical and experimental immunology,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
September 1989, Journal of leukocyte biology,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
February 1991, Infection and immunity,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
March 1995, European journal of immunology,
N A Hammoda, and A Y Negm, and E D Hussein, and M M el-Temsahy, and E A Rashwan
April 1991, The Journal of general virology,
Copied contents to your clipboard!